525
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Logistic role of carnitine shuttle system on radiation-induced L-carnitine and acylcarnitines alteration

&
Pages 1595-1608 | Received 02 Nov 2021, Accepted 18 Mar 2022, Published online: 22 Apr 2022

References

  • Adeva Andany MM, Calvo Castro I, Fernández C, Donapetry García C, Pedre Piñeiro AM. 2017. Significance of l‐carnitine for human health. IUBMB Life. 69(8):578–594.
  • Akpolat M, Gulle K, Topcu-Tarladacalisir Y, Safi Oz Z, Bakkal BH, Arasli M, Ozel Turkcu U. 2013. Protection by L-carnitine against radiation-induced ileal mucosal injury in the rat: pattern of oxidative stress, apoptosis and cytokines. Int J Radiat Biol. 89(9):732–740.
  • Aktoz T, Caloglu M, Yurut-Caloglu V, Yalcin O, Aydogdu N, Nurlu D, Arda E, Inci O. 2017. Histopathological and biochemical comparisons of the protective effects of amifostine and l-carnitine against radiation-induced acute testicular toxicity in rats. Andrologia. 49(9):e12754.
  • Albers S, Marsden D, Quackenbush E, Stark AR, Levy HL, Irons M. 2001. Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry. Pediatrics. 107(6):E103.
  • Al-Sannaa NA, Cheriyan GM. 2010. Carnitine-acylcarnitine translocase deficiency. Clinical course of three Saudi children with a severe phenotype. Saudi Med J. 31(8):931–934.
  • Altas E, Ertekin MV, Gundogdu C, Demirci E. 2006. L-carnitine reduces cochlear damage induced by gamma irradiation in Guinea pigs. Ann Clin Lab Sci. 36(3):312–318.
  • Azimzadeh O, Azizova T, Merl-Pham J, Subramanian V, Bakshi MV, Moseeva M, Zubkova O, Hauck SM, Anastasov N, Atkinson MJ, et al. 2017. A dose-dependent perturbation in cardiac energy metabolism is linked to radiation-induced ischemic heart disease in Mayak nuclear workers. Oncotarget. 8(6):9067–9078.
  • Babicova A, Havlinova Z, Hroch M, Rezacova M, Pejchal J, Vavrova J, Chladek J. 2013. In vivo study of radioprotective effect of NO-synthase inhibitors and acetyl-L-carnitine. Physiol Res. 62(6):701–710.
  • Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ, Sklar C, Forman S, Weisdorf D, Gurney JG, et al. 2007. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 109(4):1765–1772.
  • Barish GD, Narkar VA, Evans RM. 2006. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest. 116(3):590–597.
  • Barjaktarovic Z, Merl-Pham J, Braga-Tanaka I, Tanaka S, Hauck SM, Saran A, Mancuso M, Atkinson MJ, Tapio S, Azimzadeh O. 2019. Hyperacetylation of cardiac mitochondrial proteins is associated with metabolic impairment and sirtuin downregulation after chronic total body irradiation of ApoE -/- mice. IJMS. 20(20):5239.
  • Bennett MJ, Santani AB. 1993. Carnitine palmitoyltransferase 1A deficiency. https://www.ncbi.nlm.nih.gov/books/NBK1527/.
  • Bennett MJ. 2007. Assays of fatty acid beta-oxidation activity. Methods Cell Biol. 80:179–197.
  • Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. 2004. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 25(5-6):495–520.
  • Calo LA, Pagnin E, Davis PA, Semplicini A, Nicolai R, Calvani M, Pessina AC. 2006. Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol. 107(1):54–60.
  • Caloglu M, Yurut-Caloglu V, Durmus-Altun G, Oz-Puyan F, Ustun F, Cosar-Alas R, Saynak M, Parlar S, Turan FN, Uzal C. 2009. Histopathological and scintigraphic comparisons of the protective effects of L-carnitine and amifostine against radiation-induced late renal toxicity in rats. Clin Exp Pharmacol Physiol. 36(5-6):523–530.
  • Carracedo A, Cantley LC, Pandolfi PP. 2013. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 13(4):227–232.
  • Casals N, Zammit V, Herrero L, Fado R, Rodriguez-Rodriguez R, Serra D. 2016. Carnitine palmitoyltransferase 1C: from cognition to cancer. Prog Lipid Res. 61:134–148.
  • Cheema AK, Mehta KY, Rajagopal MU, Wise SY, Fatanmi OO, Singh VK. 2019. Metabolomic studies of tissue injury in nonhuman primates exposed to gamma-radiation. Int J Mol Sci. 20(13):3360.
  • Chen S, Zhu B, Yin C, Liu W, Han C, Chen B, Liu T, Li X, Chen X, Li C, et al. 2017. Palmitoylation-dependent activation of MC1R prevents melanomagenesis. Nature. 549(7672):399–403.
  • Djouadi F, Bastin J. 2008. PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis. 31(2):217–225.
  • Du Q, Tan Z, Shi F, Tang M, Xie L, Zhao L, Li Y, Hu J, Zhou M, Bode A, et al. 2019. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation. Cancer Sci. 110(6):2050–2062.
  • Düzenli U, Altun Z, Olgun Y, Aktaş S, Pamukoğlu A, Çetinayak HO, Bayrak AF, Olgun L. 2019. Role of N-acetyl cysteine and acetyl-l-carnitine combination treatment on DNA-damage-related genes induced by radiation in HEI-OC1 cells. Int J Radiat Biol. 95(3):298–306.
  • Eaton S. 2002. Control of mitochondrial beta-oxidation flux. Prog Lipid Res. 41(3):197–239.
  • Fingerhut R, Roschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, Superti-Furga A, Troxler H, Liebl B, Olgemoller B, et al. 2001. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem. 47(10):1763–1768.
  • Fischer-Valuck BW, Gay HA, Patel S, Baumann BC, Michalski JM. 2019. A brief review of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy boost for high-risk prostate. Front Oncol. 9:1378.
  • Foster DW. 2004. The role of the carnitine system in human metabolism. Ann N Y Acad Sci. 1033:1–16.
  • Giancaterini A, De Gaetano A, Mingrone G, Gniuli D, Liverani E, Capristo E, Greco AV. 2000. Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism. 49(6):704–708.
  • Giordano A, Calvani M, Petillo O, Grippo P, Tuccillo F, Melone MA, Bonelli P, Calarco A, Peluso G. 2005. TBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1. Cell Death Differ. 12(6):603–613.
  • Golla S, Golla JP, Krausz KW, Manna SK, Simillion C, Beyoğlu D, Idle JR, Gonzalez FJ. 2017. Metabolomic analysis of mice exposed to gamma radiation reveals a systemic understanding of total-body exposure. Radiat Res. 187(5):612–629.
  • Goudarzi M, Mak TD, Chen C, Smilenov LB, Brenner DJ, Fornace AJ. 2014b. The effect of low dose rate on metabolomic response to radiation in mice. Radiat Environ Biophys. 53(4):645–657.
  • Goudarzi M, Weber W, Mak TD, Chung J, Doyle-Eisele M, Melo D, Brenner DJ, Guilmette RA, Fornace AJ. 2014a. Development of urinary biomarkers for internal exposure by cesium-137 using a metabolomics approach in mice. Radiat Res. 181(1):54–64.
  • Goudarzi M, Weber WM, Mak TD, Chung J, Doyle-Eisele M, Melo DR, Brenner DJ, Guilmette RA, Fornace AJ. 2015a. Metabolomic and lipidomic analysis of serum from mice exposed to an internal emitter, cesium-137, using a shotgun LC-MS(E) approach. J Proteome Res. 14(1):374–384.
  • Goudarzi M, Weber WM, Mak TD, Chung J, Doyle-Eisele M, Melo DR, Strawn SJ, Brenner DJ, Guilmette RA, Albert J, et al. 2015b. A comprehensive metabolomic investigation in urine of mice exposed to strontium-90. Radiat Res. 183(6):665–674.
  • Gulcin I. 2006. Antioxidant and antiradical activities of L-carnitine. Life Sci. 78(8):803–811.
  • Hagenbuchner J, Scholl-Buergi S, Karall D, Ausserlechner MJ. 2018. Very long-/ and long chain-3-hydroxy acyl CoA dehydrogenase deficiency correlates with deregulation of the mitochondrial fusion/fission machinery. Sci Rep. 8(1):3254.
  • Han S, Wei R, Zhang X, Jiang N, Fan M, Huang JH, Xie B, Zhang L, Miao W, Butler AC-P, et al. 2019. CPT1A/2-Mediated FAO enhancement—a metabolic target in radioresistant breast cancer. Front Oncol. 9:1201.
  • Heiner-Fokkema MR, Vaz FM, Maatman R, Kluijtmans LA, van Spronsen FJ, Reijngoud DJ. 2017. Reliable diagnosis of carnitine palmitoyltransferase type IA deficiency by analysis of plasma acylcarnitine profiles. JIMD Rep. 32:33–39.
  • Hinzman CP, Baulch JE, Mehta KY, Girgis M, Bansal S, Gill K, Li Y, Limoli CL, Cheema AK. 2019. Plasma-derived extracellular vesicles yield predictive markers of cranial irradiation exposure in mice. Sci Rep. 9(1):9460.
  • Houten SM, Violante S, Ventura FV, Wanders RJ. 2016. The biochemistry and physiology of mitochondrial fatty acid β-oxidation and its genetic disorders. Annu Rev Physiol. 78:23–44.
  • Houten SM, Wanders R, Ranea-Robles P. 2020. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism. Biochim Biophys Acta Mol Basis Dis. 1866(5):165720.
  • Houten SM, Wanders RJ. 2010. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis. 33(5):469–477.
  • Ito K, Carracedo A, Weiss D, Arai F, Ala U, Avigan DE, Schafer ZT, Evans RM, Suda T, Lee CH, et al. 2012. A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med. 18(9):1350–1358.
  • Kam WW, Banati RB. 2013. Effects of ionizing radiation on mitochondria. Free Radic Biol Med. 65:607–619.
  • Kanter M, Topcu-Tarladacalisir Y, Parlar S. 2010. Antiapoptotic effect of L-carnitine on testicular irradiation in rats. J Mol Histol. 41(2-3):121–128.
  • Kaur S, Nag A, Singh AK, Sharma K. 2018. PPARγ-targeting potential for radioprotection. Curr Drug Targets. 19(15):1818–1830.
  • Kavanagh K, Dendinger MD, Davis AT, Register TC, DeBo R, Dugan G, Cline JM. 2015. Type 2 diabetes is a delayed late effect of whole-body irradiation in nonhuman primates. Radiat Res. 183(4):398–406.
  • Khan HA, Alhomida AS. 2011. A review of the logistic role of L-carnitine in the management of radiation toxicity and radiotherapy side effects. J Appl Toxicol. 31(8):707–713.
  • Kocer I, Kocer I, Taysi S, Taysi S, Ertekin MV, Ertekin MV, Karslioglu I, Karslioglu I, Gepdiremen A, Gepdiremen A, et al. 2007. The effect of L-carnitine in the prevention of ionizing radiation-induced cataracts: a rat model. Graefe Arch Clin Exp Ophthalmol. 245(4):588–594.
  • Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, et al. 2008. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7(1):45–56.
  • Laiakis EC, Mak TD, Anizan S, Amundson SA, Barker CA, Wolden SL, Brenner DJ, Fornace AJ. 2014a. Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation. Radiat Res. 181(4):350–361.
  • Laiakis EC, Strassburg K, Bogumil R, Lai S, Vreeken RJ, Hankemeier T, Langridge J, Plumb RS, Fornace AJ, Astarita G. 2014b. Metabolic phenotyping reveals a lipid mediator response to ionizing radiation. J Proteome Res. 13(9):4143–4154.
  • Li S, Gao D, Jiang Y. 2019. Function, detection and alteration of acylcarnitine metabolism in hepatocellular carcinoma. Metabolites. 9(2):36.
  • Liu J, Killilea DW, Ames BN. 2002. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A. 99(4):1876–1881.
  • Longo N, Frigeni M, Pasquali M. 2016. Carnitine transport and fatty acid oxidation. Biochimica Et Biophysica Acta Mol Cell Res. 1863(10):2422–2435.
  • Mak TD, Tyburski JB, Krausz KW, Kalinich JF, Gonzalez FJ, Fornace AJ. 2015. Exposure to ionizing radiation reveals global dose- and time-dependent changes in the urinary metabolome of rat. Metabolomics. 11(5):1082–1094.
  • Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, Neri S, Vacante M, Cammalleri L, Motta M. 2008. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Arch Gerontol Geriatr. 46(2):181–190.
  • Mangoni M, Sottili M, Gerini C, Desideri I, Bastida C, Pallotta S, Castiglione F, Bonomo P, Meattini I, Greto D, et al. 2017. A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. United European Gastroenterol J. 5(2):218–226.
  • Mansour HH. 2006. Protective role of carnitine ester against radiation-induced oxidative stress in rats. Pharmacol Res. 54(3):165–171.
  • Marcovina SM, Sirtori C, Peracino A, Gheorghiade M, Borum P, Remuzzi G, Ardehali H. 2013. Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine. Transl Res J Lab Clin Med. 161(2):73–84.
  • McCann MR, George DLRM, Rosania GR, Stringer KA. 2021. L-Carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine. Metabolites. 11(1):51.
  • McGarry JD, Brown NF. 1997. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 244(1):1–14.
  • Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, Yasui Y, Whitton JA, Stovall M, Robison LL, Oeffinger KC. 2009. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med. 169(15):1381–1388.
  • Mescka C, Moraes T, Rosa A, Mazzola P, Piccoli B, Jacques C, Dalazen G, Coelho J, Cortes M, Terra M, et al. 2011. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis. 26(1):21–28.
  • Morino K, Petersen KF, Shulman GI. 2006. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes. 55 Suppl 2:S9–S15.
  • Motoshima H, Goldstein BJ, Igata M, Araki E. 2006. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol. 574(Pt 1):63–71.
  • Muoio DM, Noland RC, Kovalik JP, Seiler SE, Davies MN, DeBalsi KL, Ilkayeva OR, Stevens RD, Kheterpal I, Zhang J, et al. 2012. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab. 15(5):764–777.
  • Mutomba MC, Yuan H, Konyavko M, Adachi S, Yokoyama CB, Esser V, McGarry JD, Babior BM, Gottlieb RA. 2000. Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. FEBS Lett. 478(1-2):19–25.
  • Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. 2006. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab. 91(11):4401–4407.
  • Niu J, Sun Y, Chen B, Zheng B, Jarugumilli GK, Walker SR, Hata AN, Mino-Kenudson M, Frank DA, Wu X. 2019. Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation. Nature. 573(7772):139–143.
  • Nylander V, Ingerslev LR, Andersen E, Fabre O, Garde C, Rasmussen M, Citirikkaya K, Baek J, Christensen GL, Aznar M, et al. 2016. Ionizing radiation potentiates high-fat diet-induced insulin resistance and reprograms skeletal muscle and adipose progenitor cells. Diabetes. 65(12):3573–3584.
  • Oudin C, Simeoni MC, Sirvent N, Contet A, Begu-Le CA, Bordigoni P, Curtillet C, Poiree M, Thuret I, Play B, et al. 2011. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood. 117(17):4442–4448.
  • Ozmen HK, Erdemci B, Askin S, Sezen O. 2017. Carnitine and adiponectin levels in breast cancer after radiotherapy. Open Med (Wars). 12(1):189–194.
  • Pannkuk EL, Laiakis EC, Authier S, Wong K, Fornace AJ. 2015. Global metabolomic identification of long-term dose-dependent urinary biomarkers in nonhuman primates exposed to ionizing radiation. Radiat Res. 184(2):121–133.
  • Pannkuk EL, Laiakis EC, Authier S, Wong K, Fornace JAJ. 2016a. Targeted metabolomics of nonhuman primate serum after exposure to ionizing radiation: potential tools for high-throughput biodosimetry. RSC Adv. 6(56):51192–51202.
  • Pannkuk EL, Laiakis EC, Garcia M, Fornace AJ, Singh VK. 2018. Nonhuman primates with acute radiation syndrome: results from a global serum metabolomics study after 7.2 Gy total-body irradiation. Radiat Res. 190(6):576–583.
  • Pannkuk EL, Laiakis EC, Gill K, Jain SK, Mehta KY, Nishita D, Bujold K, Bakke J, Gahagen J, Authier S, et al. 2019a. Liquid chromatography-mass spectrometry-based metabolomics of nonhuman primates after 4 Gy total body radiation exposure: global effects and targeted panels. J Proteome Res. 18(5):2260–2269.
  • Pannkuk EL, Laiakis EC, Girgis M, Dowd SE, Dhungana S, Nishita D, Bujold K, Bakke J, Gahagen J, Authier S, et al. 2019b. Temporal effects on radiation responses in nonhuman primates: identification of biofluid small molecule signatures by gas chromatography(-)mass spectrometry metabolomics. Metabolites. 9(5):98.
  • Pannkuk EL, Laiakis EC, Mak TD, Astarita G, Authier S, Wong K, Fornace AJ. 2016b. A lipidomic and metabolomic serum signature from nonhuman primates exposed to ionizing radiation. Metabolomics. 12(5):1–11.
  • Pekala J, Patkowska-Sokoła B, Bodkowski R, Jamroz D, Nowakowski P, Lochyński S, Librowski T. 2011. L-carnitine-metabolic functions and meaning in humans life. Curr Drug Metab. 12(7):667–678.
  • Petrick HL, Holloway GP. 2019. High intensity exercise inhibits carnitine palmitoyltransferase-I sensitivity to l-carnitine. Biochem J. 476(3):547–558.
  • Pirat C, Farce A, Lebègue N, Renault N, Furman C, Millet R, Yous S, Speca S, Berthelot P, Desreumaux P, et al. 2012. Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. J Med Chem. 55(9):4027–4061.
  • Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. 2012. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. 2003. Radiat Res. 178(2):V146–V172.
  • Ramsay RR, Gandour RD, van der Leij FR. 2001. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta. 1546(1):21–43.
  • Rebouche CJ. 2004. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 1033:30–41.
  • Reuter SE, Evans AM. 2012. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet. 51(9):553–572.
  • Rinaldo P, Cowan TM, Matern D. 2008. Acylcarnitine profile analysis. Genet Med. 10(2):151–156.
  • Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 434(7029):113–118.
  • Rutkowsky JM, Knotts TA, Ono-Moore KD, McCoin CS, Huang S, Schneider D, Singh S, Adams SH, Hwang DH. 2014. Acylcarnitines activate proinflammatory signaling pathways. Am J Physiol Endocrinol Metab. 306(12):E1378–E1387.
  • Sanli T, Rashid A, Liu C, Harding S, Bristow RG, Cutz JC, Singh G, Wright J, Tsakiridis T. 2010. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys. 78(1):221–229.
  • Sanli T, Storozhuk Y, Linher-Melville K, Bristow RG, Laderout K, Viollet B, Wright J, Singh G, Tsakiridis T. 2012. Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival. Radiother Oncol. 102(3):459–465.
  • Schaefer J, Jackson S, Taroni F, Swift P, Turnbull DM. 1997. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. J Neurol Neurosurg Psychiatry. 62(2):169–176.
  • Schooneman MG, Vaz FM, Houten SM, Soeters MR. 2013. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes. 62(1):1–8.
  • Seiler SE, Koves TR, Gooding JR, Wong KE, Stevens RD, Ilkayeva OR, Wittmann AH, DeBalsi KL, Davies MN, Lindeboom L, et al. 2015. Carnitine acetyltransferase mitigates metabolic inertia and muscle fatigue during exercise. Cell Metab. 22(1):65–76.
  • Sezen O, Ertekin MV, Demircan B, Karslioğlu I, Erdoğan F, Koçer I, Calik I, Gepdiremen A. 2008. Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced brain and retinal damages. Neurosurg Rev. 31(2):205–213, 213.
  • Shao H, Mohamed EM, Xu GG, Waters M, Jing K, Ma Y, Zhang Y, Spiegel S, Idowu MO, Fang X. 2016. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer. Oncotarget. 7(4):3832–3846.
  • Stanley CA, Sunaryo F, Hale DE, Bonnefont JP, Demaugre F, Saudubray JM. 1992. Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency. J Inherit Metab Dis. 15(5):785–789.
  • Steinberg GR, Kemp BE. 2009. AMPK in health and disease. Physiol Rev. 89(3):1025–1078.
  • Stephens FB. 2018. Does skeletal muscle carnitine availability influence fuel selection during exercise? Proc Nutr Soc. 77(1):11–19.
  • Subramanian V, Seemann I, Merl-Pham J, Hauck SM, Stewart FA, Atkinson MJ, Tapio S, Azimzadeh O. 2017. Role of TGF beta and PPAR alpha signaling pathways in radiation response of locally exposed heart: integrated global transcriptomics and proteomics analysis. J Proteome Res. 16(1):307–318.
  • Tachibana K, Kobayashi Y, Tanaka T, Tagami M, Sugiyama A, Katayama T, Ueda C, Yamasaki D, Ishimoto K, Sumitomo M, et al. 2005. Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms. Nucl Recept. 3:3.
  • Tan Z, Xiao L, Tang M, Bai F, Li J, Li L, Shi F, Li N, Li Y, Du Q, et al. 2018. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy. Theranostics. 8(9):2329–2347.
  • Tang FR, Loganovsky K. 2018. Low dose or low dose rate ionizing radiation-induced health effect in the human. J Environ Radioact. 192:32–47.
  • Tyburski JB, Patterson AD, Krausz KW, Slavík J, Albert JFJ, Gonzalez FJ, Idle JR. 2008. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res. 170(1):1–14.
  • Vaz FM, Wanders RJ. 2002. Carnitine biosynthesis in mammals. Biochem J. 361(Pt 3):417–429.
  • Vélot C, Srere PA. 2000. Reversible transdominant inhibition of a metabolic pathway. In vivo evidence of interaction between two sequential tricarboxylic acid cycle enzymes in yeast. J Biol Chem. 275(17):12926–12933.
  • Villena JA. 2015. New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond. Febs J. 282(4):647–672.
  • Violante S, Ijlst L, Ruiter J, Koster J, van Lenthe H, Duran M, de Almeida IT, Wanders RJ, Houten SM, Ventura FV. 2013a. Substrate specificity of human carnitine acetyltransferase: implications for fatty acid and branched-chain amino acid metabolism. Biochim Biophys Acta. 1832(6):773–779.
  • Violante S, Ijlst L, Te BH, Tavares DAI, Wanders RJ, Ventura FV, Houten SM. 2013b. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines. FASEB J. 27(5):2039–2044.
  • Violante S, Ijlst L, van Lenthe H, de Almeida IT, Wanders RJ, Ventura FV. 2010. Carnitine palmitoyltransferase 2: new insights on the substrate specificity and implications for acylcarnitine profiling. Biochim Biophys Acta. 1802(9):728–732.
  • Virmani A, Pinto L, Bauermann O, Zerelli S, Diedenhofen A, Binienda ZK, Ali SF, van der Leij FR. 2015. The carnitine palmitoyl transferase (CPT) system and possible relevance for neuropsychiatric and neurological conditions. Mol Neurobiol. 52(2):826–836.
  • Virmani A, Pinto L, Binienda Z, Ali S. 2013. Food, nutrigenomics, and neurodegeneration-neuroprotection by what you eat!. !Mol Neurobiol. 48(2):353–362.
  • Wang C, Rajput S, Watabe K, Liao DF, Cao D. 2010. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed). 2(2):515–526.
  • Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al. 2018. JAK/STAT3-regulated fatty acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 27(1):136–150.
  • Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vazquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, et al. 2018. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 46(D1):D608–D617.
  • Yamada K, Bo R, Kobayashi H, Hasegawa Y, Ago M, Fukuda S, Yamaguchi S, Taketani T. 2017. A newborn case with carnitine palmitoyltransferase II deficiency initially judged as unaffected by acylcarnitine analysis soon after birth. Mol Genet Metab Rep. 11:59–61.
  • Yamada K, Taketani T. 2019. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency. J Hum Genet. 64(2):73–85.
  • Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. 2004. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 161(6):622–632.
  • Yan X, Markey SP, Marupaka R, Dong Q, Cooper BT, Mirokhin YA, Wallace WE, Stein SE. 2020. Mass spectral library of acylcarnitines derived from human urine. Anal Chem. 92(9):6521–6528.
  • Yan X, Zhang G, Bie F, Lv Y, Ma Y, Ma M, Wang Y, Hao X, Yuan N, Jiang X. 2017. Eugenol inhibits oxidative phosphorylation and fatty acid oxidation via downregulation of c-Myc/PGC-1β/ERRα signaling pathway in MCF10A-ras cells. Sci Rep. 7(1):12920.
  • Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, et al. 2019. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng. 3(4):306–317.
  • Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L. 2010. L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept. 161(1-3):58–66.
  • Zannella VE, Cojocari D, Hilgendorf S, Vellanki RN, Chung S, Wouters BG, Koritzinsky M. 2011. AMPK regulates metabolism and survival in response to ionizing radiation. Radiother Oncol. 99(3):293–299.
  • Zhao H, Xi C, Tian M, Lu X, Cai TJ, Li S, Tian XL, Gao L, Liu HX, Liu KH, et al. 2020. Identification of potential radiation responsive metabolic biomarkers in plasma of rats exposed to different doses of cobalt-60 gamma rays. Dose Response. 18(4):710538894.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.